Skip to main content

Table 2 Summary of acute adverse effects in 45 patients treated with bevacizumab in combination with neoadjuvant chemoradiotherapy

From: Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study

Toxicity (NCI-CTC Version 3.0)

No. of patients

Grade 1

Grade 2

Grade 3

Grade 4

Hematological

 Leukopenia

11

8

3

1

 Neutropenia

16

6

1

1

 Thrombocytopenia

1

0

0

0

Non-hematological

 Diarrhea

10

2

2

0

 Nausea or vomiting

17

2

0

0

 Hand-foot syndrome

3

0

0

0

 Radiation dermatitis

4

0

1

0

 Neuropathy

15

0

0

0

 Proteinuria

2

0

0

0